Inhibitory effect of genistein on bone resorption in tissue culture

被引:114
作者
Yamaguchi, M
Gao, YH
机构
[1] Lab. of Endocrinol./Molec. Metab., Grad. of Sch. of Nutritional Sci., University of Shizuoka
[2] Lab. of Endocrinol./Molec. Metab., Grad. Sch. of Nutritional Sciences, University of Shizuoka, Shizuoka City 422
关键词
genistein; parathyroid hormone; estrogen; bone resorption; bone tissue culture;
D O I
10.1016/S0006-2952(97)00402-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effect of genistein on bone resorption in vitro was investigated. Femoral-metaphyseal tissues obtained from elderly female rats were cultured for 48 hr in Dulbecco's modified Eagle's medium (high glucose, 4.5%) supplemented with antibiotics and bovine serum albumin. The experimental cultures contained 10(-7) to 10(-3) M genistein. The bone-resorbing factors parathyroid hormone (1-34) (PTH; 10(-7) M), prostaglandin E-2 (PGE(2); 10(-5) M), and lipopolysaccharide (10 mu g/mL) caused a significant decrease in bone calcium content. The decrease in bone calcium content induced by bone-resorbing factors was inhibited completely by genistein (10(-7) to 10(-5) M). In addition, this isoflavonoid (10(-5) M) completely inhibited the PTH (10(-7) M)- or PGE(2) (10(-5) M)-induced increase in medium glucose consumption and lactic acid production by bone tissues. Moreover, genistein (10(-5) M) blocked both PTH (10(-7) M)-increased acid phosphatase and -decreased alkaline phosphatase activities of bone tissues. The inhibitory effect of genistein (10(-5) M) on PTH (10(-7) M)-stimulated bone resorption was clearly prevented by the presence of 10(-6) M tamoxifen, an anti-estrogen reagent. Genistein (10(-5) M) did not further enhance the inhibitory effect of estrogen (10(-9) M) on PTH-stimulated bone resorption. These findings indicate that genistein has a direct inhibitory effect on bone resorption in tissue culture in vitro. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 29 条
[1]   Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis [J].
Arjmandi, BH ;
Alekel, L ;
Hollis, BW ;
Amin, D ;
StacewiczSapuntzakis, M ;
Guo, P ;
Kukreja, SC .
JOURNAL OF NUTRITION, 1996, 126 (01) :161-167
[2]  
BERGAMASCHI G, 1993, LEUKEMIA, V7, P2012
[3]  
Blair HC, 1996, J CELL BIOCHEM, V61, P629, DOI 10.1002/(SICI)1097-4644(19960616)61:4<629::AID-JCB17>3.3.CO
[4]  
2-E
[5]   Nutritional aspects of hip fractures [J].
Bonjour, JP ;
Schurch, MA ;
Rizzoli, R .
BONE, 1996, 18 (03) :S139-S144
[6]   AN IMPROVED PROCEDURE FOR IDENTIFYING AND QUANTITATING PROTEIN PHOSPHATASES IN MAMMALIAN-TISSUES [J].
COHEN, P ;
KLUMPP, S ;
SCHELLING, DL .
FEBS LETTERS, 1989, 250 (02) :596-600
[7]   EPIDEMIOLOGY OF OSTEOPOROSIS [J].
COOPER, C ;
MELTON, LJ .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1992, 3 (06) :224-229
[8]   EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES [J].
CUMMINGS, SR ;
KELSEY, JL ;
NEVITT, MC ;
ODOWD, KJ .
EPIDEMIOLOGIC REVIEWS, 1985, 7 :178-208
[9]   COMPARISON OF BONE AND PARATHYROID-HORMONE AS STIMULATORS OF OSTEOCLAST DEVELOPMENT AND ACTIVITY IN CALVARIAL CELL-CULTURES FROM NORMAL AND OSTEOPETROTIC (MI/MI) MICE [J].
GRAVES, L ;
JILKA, RL .
JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 145 (01) :102-109
[10]   SPECIFIC DETERMINATION OF BLOOD GLUCOSE WITH O-TOLUIDINE [J].
HYVARINEN, A ;
NIKKILA, EA .
CLINICA CHIMICA ACTA, 1962, 7 (01) :140-&